Global In Vitro Fertilization (IVF) Market Report 2016-2022 – Insights, Opportunity Analysis, Market Shares and Forecasts – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global
In Vitro Fertilization (IVF) Market Insights, Opportunity Analysis,
Market Shares and Forecast 2016 – 2022”
report to their

Infertility is one of the major concerns in the world. One out of six
couples in the world suffers from some form of infertility. About 10%
women aged 20-44 suffer from infertility. There are various causes for
infertility which include physiological (20-30% cases), some cases
include genetically induced disorders whereas sometimes it may be self
induced as in case of contraceptive surgeries. The market is driven by
rising awareness amongst couples, a strong and developed health
structure in developing nations, low cost treatment options available,
and rise in the new methods like in vitro activation and surrogacy.

The testing and treatment market is growing at a faster rate in males
than females. The earlier social taboos among men regarding male
fertility have been declining, leading to increase in the male
infertility testing and treatment market.

The cost of fertility treatment varies vastly from country to country
leading to a rise in medial tourism in relationship with fertility
treatments Israel is one of the leading countries with high quality
treatments for infertility. The success rate of infertility treatment in
Israel is around 46% which in one of the best globally .

The companies profile in this report include:

  • Andrology Solutions
  • Auxilium Pharmaceuticals
  • Auxogyn
  • Ferring Pharmaceuticals
  • Genea
  • Halotech DNA
  • Irvine Scientific
  • Merck Serono
  • Origio
  • Ovascience
  • Vitrolife AB

Key Topics Covered:

Chap 1. Executive Summary

Chap 2. Market overview

2.1. Market Share for Drug & Hormone Therapy

2.2. Key buying criteria

2.2.1. Treatment options

2.2.2. Quality of medical procedures

2.2.3. Price of treatments

2.2.4. Shift towards medical tourism

2.2.5. Reimbursement

2.3. Key Findings

2.3.1. highest growth in Male infertility treatment segment

2.3.2. Fertility tourism- The biggest growing trend

2.3.3. Upper middle income group is the key target

2.3.4. Regulatory environment key market enabler

2.3.5. Surrogacy preferred for failures in IVF treatments

2.3.6. Technological advancement enhancing success rates of fertility

Chap 3. Male and Female Infertility

3.1. Causes

3.2. Ethical issues in infertility treatment

Chap 4. Market Determinants

4.1. Market Drivers

4.1.1. Rise in infertility

4.1.2. Fertility Tourism

4.1.3. Surrogacy also responsible for fertility tourism

4.1.4. Technological advancement in healthcare domain

4.1.5. Increase in success rate of treatments

4.1.6. Increasing acceptance of donor eggs by consumers

4.2. Market Restraints

4.2.1. Expensive procedure

4.2.2. Legal issues

4.3. Market Opportunities

4.3.1. Global requirement for low cost instruments and drugs in IVF

4.3.2. IVF an attractive sector for investment for private equity

4.3.3. Reproductive tourism

4.4. Market Challenges

4.4.1. Cost barrier for locals in emerging economies

4.4.2. Low acceptance of infertility treatment amongst men

4.4.3. Multiple births and birth defects

Chap 5. Market Segmentation

5.1. Male Infertility Market

5.2. Female infertility

Chap 6. IVF & Infertility market geography wise

Chap 7. Company Profiling

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women’s